Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Bichet

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Trends in Endocrinology and Metabolism: TEM|June 30, 2004
Pharmacological chaperones: potential treatment for conformational diseasesVirginie Bernier, Monique Lagacé, Daniel G Bichet, et al.
Endocrinology|September 12, 2014
Diabetes insipidus: celebrating a century of vasopressin therapySana Qureshi, Sneha Galiveeti, Daniel G Bichet, et al.
Pediatric Nephrology (Berlin, Germany)|November 12, 2022
What's in a name? That which we call diabetes does not taste sweet!Detlef Bockenhauer, Nine V A M Knoers, Daniel G Bichet
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2004
The dilemma of diagnosing the cause of hypernatraemia: drinking habits vs diabetes insipidusBiruh Workeneh, Arun Balakumaran, Daniel G Bichet, et al.
The Journal of Membrane Biology|August 17, 2010
Stimulating effect of external Myo-inositol on the expression of mutant forms of aquaporin 2Yoann Lussier, Pierre Bissonnette, Daniel G Bichet, et al.
Molecular Genetics and Metabolism Reports|August 2, 2019
The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry diseaseRaphael Schiffmann, Daniel G Bichet, Elfrida Benjamin, et al.
NDT Plus|May 8, 2015
A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidusDaisuke Kobayashi, Shashi K Nagaraj, Jen-Jar Lin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Assessment of renal pathology and dysfunction in children with Fabry diseaseUma Ramaswami, Behzad Najafian, Arrigo Schieppati, et al.
Journal of the American Society of Nephrology : JASN|July 4, 2008
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonistsJulie Perucca, Daniel G Bichet, Pascale Bardoux, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2005
Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humansLise Bankir, Sandrine Fernandes, Pascale Bardoux, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Trends in Endocrinology and Metabolism: TEM|June 30, 2004
Pharmacological chaperones: potential treatment for conformational diseasesVirginie Bernier, Monique Lagacé, Daniel G Bichet, et al.
Endocrinology|September 12, 2014
Diabetes insipidus: celebrating a century of vasopressin therapySana Qureshi, Sneha Galiveeti, Daniel G Bichet, et al.
Pediatric Nephrology (Berlin, Germany)|November 12, 2022
What's in a name? That which we call diabetes does not taste sweet!Detlef Bockenhauer, Nine V A M Knoers, Daniel G Bichet
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2004
The dilemma of diagnosing the cause of hypernatraemia: drinking habits vs diabetes insipidusBiruh Workeneh, Arun Balakumaran, Daniel G Bichet, et al.
The Journal of Membrane Biology|August 17, 2010
Stimulating effect of external Myo-inositol on the expression of mutant forms of aquaporin 2Yoann Lussier, Pierre Bissonnette, Daniel G Bichet, et al.
Molecular Genetics and Metabolism Reports|August 2, 2019
The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry diseaseRaphael Schiffmann, Daniel G Bichet, Elfrida Benjamin, et al.
NDT Plus|May 8, 2015
A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidusDaisuke Kobayashi, Shashi K Nagaraj, Jen-Jar Lin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Assessment of renal pathology and dysfunction in children with Fabry diseaseUma Ramaswami, Behzad Najafian, Arrigo Schieppati, et al.
Journal of the American Society of Nephrology : JASN|July 4, 2008
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonistsJulie Perucca, Daniel G Bichet, Pascale Bardoux, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2005
Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humansLise Bankir, Sandrine Fernandes, Pascale Bardoux, et al.
Pageof 15